Cerebral White Matter Hypoperfusion Increases with Small-Vessel Disease Burden. Data From the Third International Stroke Trial

Journal of Stroke and Cerebrovascular Diseases

Volumn 26, Issue 7, 2017, Pages 1506-1513

  Arba, Francesco ^a,b,c,d   Mair, Grant ^b,c,d   Carpenter, Trevor ^b,c   Sakka, Eleni ^b,c,d   Sandercock, Peter A G ^d   Lindley, Richard I ^e   Inzitari, Domenico ^a   Wardlaw, Joanna M ^b,c,d  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Brain Research Imaging Centre SINAPSE Collaboration   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

cerebral blood flow; Cerebral small vessel disease; CT perfusion; stroke; white matter

Indexed keywords

AGED; ARTICLE; BLOOD PRESSURE; BRAIN ATROPHY; BRAIN PERFUSION; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; FEMALE; HEMISPHERE; HUMAN; HYPERTENSION; LACUNAR STROKE; LATERAL BRAIN VENTRICLE; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MEAN TRANSIT TIME; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; VERY ELDERLY; WHITE MATTER; ATROPHY; BLOOD FLOW VELOCITY; BRAIN CIRCULATION; COMPLICATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; LEUKOENCEPHALOPATHY; ODDS RATIO; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCINTIGRAPHY; STATISTICAL MODEL; VASCULARIZATION; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ATROPHY; BLOOD FLOW VELOCITY; CEREBRAL SMALL VESSEL DISEASES; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; LEUKOARAIOSIS; LEUKOENCEPHALOPATHIES; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; ODDS RATIO; PERFUSION IMAGING; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; WHITE MATTER;

EID: 85019737861     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2017.03.002     Document Type: Article

References (33)

1. Wardlaw, J.M., Smith, C., Dichgans, M., Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 12 (2013), 483–497.
2. Wardlaw, J.M., Smith, E.E., Biessels, G.J., et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12 (2013), 822–838.
3. Markus, H.S., Lythgoe, D.J., Ostegaard, L., et al. Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. J Neurol Neurosurg Psychiatry 69 (2000), 48–53.
4. O'Sullivan, M., Lythgoe, D.J., Pereira, A.C., et al. Patterns of cerebral blood flow reduction in patients with ischaemic leukoaraiosis. Neurology 59 (2002), 321–326.
5. Vernooij, M.W., van der Lugt, A., Ikram, M.A., et al. Total cerebral blood flow and total brain perfusion in the general population: the Rotterdam Scan Study. J Cereb Blood Flow Metab 28 (2008), 412–419.
6. Van der Veen, P.H., Muller, M., Vincken, K.L., et al. Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow: the second manifestations of arterial disease-magnetic resonance study. Stroke 46 (2015), 1233–1238.
7. Appelman, A.P., van der Graaf, Y., Vincken, K.L., et al. Total cerebral blood flow, white matter lesions and brain atrophy: the SMART-MR study. J Cereb Blood Flow Metab 28 (2008), 633–639.
8. Davis, S.M., Donnan, G.A., Parsons, M.W., et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 7 (2008), 299–309.
9. Bivard, A., Levi, C., Krishnamurthy, V., et al. Perfusion computed tomography to assist decision making for stroke thrombolysis. Brain 138 (2015), 1919–1931.
10. IST-3 Collaborative Group. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial. Lancet Neurol 14 (2015), 485–496.
11. Staals, J., Makin, S.D., Doubal, F.N., et al. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology 83 (2014), 1228–1234.
12. Sandercock, P., Lindley, R., Wardlaw, J., et al. Third International stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials 17 (2008), 9–37.
13. IST-3 collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial [IST-3]): a randomised controlled trial. Lancet 379 (2012), 2352–2363.
14. Bamford, J., Sandercock, P., Dennis, M., et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337 (1991), 1521–1526.
15. Bamford, J.M., Sandercock, P., Warlow, C., et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke, 20, 1989, 828.
16. Van Swieten, J.C., Hijdra, A., Koudstaal, P.J., et al. Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry 53 (1990), 1080–1083.
17. Wardlaw, J.M., von Kummer, R., Carpenter, T., et al. Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischaemic stroke. Int J Stroke 10 (2015), 956–968.
18. Wardlaw, J.M., Carpenter, T., Sakka, E., et al. Imaging perfusion deficits, arterial patency and thrombolysis safety and efficacy in acute ischaemic stroke. An observational study of the effect of advanced imaging methods in The Third International Stroke Trial (IST-3), a randomised controlled trial. Eff Mech Eval, 1, 2014.
19. Kane, I., Carpenter, T., Chappell, F., et al. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischaemic stroke. Effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores and radiological outcomes. Stroke 38 (2007), 3158–3164.
20. Carpenter, T., Armitage, P.A., Bastin, M.E., et al. DSC perfusion MRI—quantification and reduction of systematic errors arising in areas of reduced cerebral blood flow. Magn Reson Med 56 (2006), 1342–1349.
21. Shi, Y., Thrippleton, M.J., Makin, S.D., et al. Cerebral blood flow in small vessel disease: a systematic review and meta-analysis. J Cereb Blood Flow Metab, 36, 2016 in press.
22. Immink, R.V., van Montfrans, G.A., Stam, J., et al. Dynamic cerebral autoregulation in acute lacunar and middle cerebral artery territory ischaemic stroke. Stroke 36 (2005), 2595–2600.
23. Wardlaw, J.M., Doubal, F.N., Eadie, E., et al. Little association between intracranial arterial stenosis and lacunar stroke. Cerebrovasc Dis 31 (2011), 12–18.
24. Huynh, T.J., Murphy, B., Pettersen, J.A., et al. CT perfusion quantification of small-vessel ischaemic severity. AJNR Am J Neuroradiol 29 (2008), 1831–1836.
25. Black, S., Gao, F., Bilbao, J., Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke 40:Suppl 3 (2009), S48–S52.
26. Iwamoto, T., Kubo, H., Takasaki, M., Platelet activation in the cerebral circulation in different subtypes of ischaemic stroke and Binswanger's disease. Stroke 26 (1995), 52–56.
27. Tomimoto, H., Akiguchi, I., Wakita, H., et al. Coagulation activation in patients with Binswanger disease. Arch Neurol 56 (1999), 1104–1108.
28. Wardlaw, J.M., Doubal, F., Armitage, P., et al. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 65 (2009), 194–202.
29. Poggesi, A., Pasi, M., Pescini, F., et al. Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review. J Cereb Blood Flow Metab 36 (2016), 72–94, 10.1038/jcbfm.2015.116.
30. Stevenson, S.F., Doubal, F.N., Shuler, K., et al. A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke 41 (2010), e434–e442.
31. Wiseman, S., Marlborough, F., Doubal, F., et al. Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis. Cerebrovasc Dis 37 (2014), 64–75.
32. Ostergaard, L., Sondergaard, T., Moreton, F., et al. Cerebral small vessel disease: capillary pathways to stroke and cognitive decline. J Cereb Blood Flow Metab 36 (2015), 302–325.
33. Klarenbeek, P., van Oostenbrugge, R.J., Rouhl, R.P., et al. Ambulatory blood pressure in patients with lacunar stroke: association with total MRI burden of cerebral small vessel disease. Stroke 44 (2013), 2995–2999.